XLS Medical has a unique triple action effect:

  • Binds up to 28% of fat intake
  • Reduces appetite and sweet cravings
  • Improves gastrointestinal transit
XLS Medical is also good for your health and has a proven effect on:
  • Cholesterol reduction
  • Metabolic syndrome reduction
Who is it for?

XLS Medical is suitable for any adult who is overweight no matter their diet. It can help you to lose up to 3x more weight than with a diet alone.*

How to take XLS Medical?
  • Take 3x2 tablets / day
  • If you are eating, pills should be taken after meals with liquid
  • Do not exceed 6 tablets a day
  • Take XLS Medical for one month or more, depending on your weight loss targets
How it works
  • XLS Medical contains ,a unique substance based on vegetable fibres and enriched with the fat soluble vitamins A, D and E.
  • XLS Medical with vitamins binds up to 28% of dietary fats in the stomach by absorbing the fat molecules to form a fat-fibre complex. It ensures optimum fat binding in the first phase and, in the second phase, fat-soluble vitamins are released into the body to ensure optimum vitamin absorption.



Clinically proven
The excellent fat absorption capacity of XLS Medical has been proven in numerous clinical studies:


  • XLS Medical reduces fat absorption by up to 28% with no undesirable side effects
  • XLS Medical reduces LDL-Cholesterol (bad cholesterol) by 10% within 14 days4
  • XLS Medical reduces metabolic syndrome by 39% within 42 days4
  • XLS Medical has a proven effect on the feeling of fullness: 80% of patients reported a moderate to high increase in fullness2
  • XLS Medical helps you to lose up to 3X more weight than with a diet alone.*
  • All these results are achieved with no undesirable side effects

*Grube et al. 2013. See the study. Results may vary from individual to individual

1. In vivo Pilot Clinical Study, placebo-controlled, double-blind clinical study, conducted by CERN, (Centre d’Enseignement et de Recherche en Nutrition) in France, 2003.

2. In vivo, 2-armed, randomised, placebo-controlled, double-blind study, conducted in Germany, 2009.

3. Double-blind, randomized, placebo-controlled, crossover clinical investigation to evaluate the effect of Litramine on fecal fat excretion in healthy subjects, Germany, 2012.

4. Linarès E. et al., The effect of NeOpuntia on Blood Lipid Parameters – Risk Factors for the Metabolic Syndrome (Syndrome X), Advances in Therapy, September/October 2007.